STK4
protein-codingserine/threonine kinase 4
Gene summary
The protein encoded by this gene is a cytoplasmic kinase that is structurally similar to the yeast Ste20p kinase, which acts upstream of the stress-induced mitogen-activated protein kinase cascade. The encoded protein can phosphorylate myelin basic protein and undergoes autophosphorylation. A caspase-cleaved fragment of the encoded protein has been shown to be capable of phosphorylating histone H2B. The particular phosphorylation catalyzed by this protein has been correlated with apoptosis, and it's possible that this protein induces the chromatin condensation observed in this process. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~117.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013934
Submitter: ClinGen
*STK4* was first reported in relation to autosomal recessive combined immunodeficiency in 2012 (Abdollahpour H, et al., 2012, PMID: 22294732; Nehme NT, et al., 2012, PMID: 22174160). Serine/threonine kinase 4 (*STK4*), encodes mammalian Sterile 20-like kinase 1 (MST1; distinct from the gene *MST1* or macrophage stimulating 1) which is involved in cell death, following caspase-cleavage, it enters the nucleus and induces chromatin condensation followed by internucleosomal DNA fragmentation. It is a key component of the Hippo signaling pathway, which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. *STK4* deficiency is characterized by a progressive loss of naive T cells, the consequences of which include recurrent bacterial and viral infections and autoimmune manifestations. Curated evidence supporting the gene-disease relationship includes 6 probands plus 6 additional affected family members, with biallelic loss of function (nonsense and frameshift) variants, reported in 5 publications (PMIDs: 22294732, 22174160, 22952854, 26117625, 26801501). Parents and healthy siblings were heterozygous for the mutation, consistent with autosomal recessive inheritance (PMID: 22294732), with no evidence of dominant disease by haploinsufficiency. This gene-disease relationship is also supported by experimental evidence, including its enhanced expression in hematopoietic tissues (PMID: 22174160) and its function in apoptosis (PMID: 11278283), which is consistent with increased cell death of naive and proliferating T cells leading to lymphopenia in patients. This function is altered in patient cells (PMID: 22294732), which also have altered expression of Foxo1, Il7Rα, L-selectin, and CCR7, which can cause altered T-cell homing to secondary lymphoid organs (PMID: 22174160). Models have recapitulated the T lymphopenia with profound loss of naïve T cells in both knockout and cell-specific knockout mice (PMIDs: 19073936, 19692642). More evidence is available in the literature, but the maximum score was reached. In summary, *STK4* is definitively associated with autosomal recessive combined immunodeficiency. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen SCID/CID GCEP on the meeting date May 19, 2022 (SOP Version 8).
Inheritance Pattern: AR
Disease ID:MONDO:0013934
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0013934
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0013934
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0013934
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious; Cardiovascular
Intervention: Allergy/Immunology/Infectious; Cardiovascular
Rationale: Individuals are susceptible to recurrent and severe viral, bacterial, and fungal infections (as well as sequelae such as EBV-related lymphoma), and and prophylaxis, as well as prompt and aggressive treatment of infections may be beneficial; Individuals may have cardiovascular anomalies, and surveillance (including with echocardiogram) may allow early detection and management; HSCT has been described
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to STK4 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_006282.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 70 | 71 | |||
| missense | 120 | 9 | 1 | 130 | ||
| nonsense | 9 | 4 | 1 | 14 | ||
| start loss | 1 | 1 | ||||
| frameshift | 3 | 3 | ||||
| splice donor/acceptor (+/-2bp) | 3 | 3 | 6 | |||
| Total | 12 | 7 | 126 | 79 | 1 | 225 |
Highest pathogenic variant AF is 0.00000868992
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_006273.1 | 11 | MANE Select | |
| Ensembl | ENSP00000361892.3 | 11 | MANE Select | |
| RefSeq | NP_001339314.1 | 11 | Standard | |
| Ensembl | ENSP00000361887.1 | 11 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Non-small cell lung cancer - Homo sapiens (human)
- FoxO signaling pathway - Homo sapiens (human)
- Ras signaling pathway - Homo sapiens (human)
- MAPK signaling pathway - Homo sapiens (human)
- Pathways in cancer - Homo sapiens (human)
Biological Process
- cell morphogenesis
- branching involved in blood vessel morphogenesis
- neural tube formation
- positive regulation of protein phosphorylation
- endocardium development
Molecular Function
- magnesium ion binding
- protein kinase activity
- protein serine/threonine kinase activity
- protein binding
- ATP binding
Cellular Component
- nucleus
- nucleoplasm
- cytoplasm
- cytosol
- nuclear body
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000372806
- Coding exons
- 11
- Length
- 113486
- Individuals with no LoFs
- 125726
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 22
- Defined
- 125748
- p
- 0.0000875
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.47 | 197 | 264 | 0.746 | 0.0000137 | 3225 |
| Missense (PolyPhen) | 37 | 82.455 | 0.44873 | 984 | ||
| Synonymous | 0.383 | 85 | 89.6 | 0.949 | 0.00000463 | 879 |
| Loss of Function | 3.55 | 9 | 30.0 | 0.300 | 0.00000185 | 323 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000087 | 0.000087 | rare |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.00014 | 0.00014 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Stress-activated, pro-apoptotic kinase which, following caspase-cleavage, enters the nucleus and induces chromatin condensation followed by internucleosomal DNA fragmentation. Key component of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. STK3/MST2 and STK4/MST1 are required to repress proliferation of mature hepatocytes, to prevent activation of facultative adult liver stem cells (oval cells), and to inhibit tumor formation (By similarity). Phosphorylates 'Ser-14' of histone H2B (H2BS14ph) during apoptosis. Phosphorylates FOXO3 upon oxidative stress, which results in its nuclear translocation and cell death initiation. Phosphorylates MOBKL1A, MOBKL1B and RASSF2. Phosphorylates TNNI3 (cardiac Tn-I) and alters its binding affinity to TNNC1 (cardiac Tn-C) and TNNT2 (cardiac Tn-T). Phosphorylates FOXO1 on 'Ser-212' and regulates its activation and stimulates transcription of PMAIP1 in a FOXO1-dependent manner. Phosphorylates SIRT1 and inhibits SIRT1-mediated p53/TP53 deacetylation, thereby promoting p53/TP53 dependent transcription and apoptosis upon DNA damage. Acts as an inhibitor of PKB/AKT1. Phosphorylates AR on 'Ser-650' and suppresses its activity by intersecting with PKB/AKT1 signaling and antagonizing formation of AR-chromatin complexes. {ECO:0000250|UniProtKB:Q9JI11, ECO:0000269|PubMed:11278283, ECO:0000269|PubMed:11517310, ECO:0000269|PubMed:12757711, ECO:0000269|PubMed:15109305, ECO:0000269|PubMed:16510573, ECO:0000269|PubMed:16751106, ECO:0000269|PubMed:16930133, ECO:0000269|PubMed:17932490, ECO:0000269|PubMed:18328708, ECO:0000269|PubMed:18986304, ECO:0000269|PubMed:19525978, ECO:0000269|PubMed:21212262, ECO:0000269|PubMed:21245099, ECO:0000269|PubMed:21512132, ECO:0000269|PubMed:8702870, ECO:0000269|PubMed:8816758}.;
- Disease
- DISEASE: T-cell immunodeficiency, recurrent infections, and autoimmunity with or without cardiac malformations (TIIAC) [MIM:614868]: A primary T-cell immunodeficiency syndrome characterized by progressive loss of naive T-cells, recurrent bacterial, viral, and fungal infections, warts, and abscesses, autoimmune manifestations, and cardiac malformations, including atrial septal defect. {ECO:0000269|PubMed:22294732}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.120
Intolerance Scores
- LoFtool
- 0.526
- RVIS EVS
- -0.42
- RVIS percentile EVS
- 25.56
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.999
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |